Onkologi og hematologi (NFR-evaluering)
- Prosjektnummer
- 911146
- Ansvarlig person
- Olav Dahl og Øystein Bruserud
- Institusjon
- Helse Bergen/ Universitetet i Bergen
- Prosjektkategori
- Strategiske midler - belønning NFR
- Helsekategori
- Oncogenesis & Cancer Research
- Forskningsaktivitet
- Klinisk forskning
Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Eye 2008 Nov;22(11):1398-403. Epub 2007 jun 22
PMID: 17585309
Incidence of iris melanoma in western Norway.
Acta Ophthalmol 2008 Feb;86(1):116-7. Epub 2007 aug 28
PMID: 17725612
Palliative surgery for rectal cancer in a national cohort.
Colorectal Dis 2008 May;10(4):336-43. Epub 2007 sep 13
PMID: 17868410
Late gastrointestinal morbidity after three-dimensional conformal radiation therapy for prostate cancer fades with time in contrast to genitourinary morbidity.
Int J Radiat Oncol Biol Phys 2008 Apr;70(5):1478-86. Epub 2007 des 3
PMID: 18060703
[Anal cancer]
Tidsskr Nor Laegeforen 2008 Jan;128(2):198-200.
PMID: 18202733
Current status of antivascular therapy and targeted treatment in the clinic.
Int J Hyperthermia 2008 Feb;24(1):97-110.
PMID: 18214773
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour.
Radiother Oncol 2008 Mar;86(3):435-42. Epub 2008 mar 4
PMID: 18313158
Gene expression reveals two distinct groups of anal carcinomas with clinical implications.
Br J Cancer 2008 Apr;98(7):1264-73. Epub 2008 mar 18
PMID: 18349847
Chronic cancer-related fatigue in long-term survivors of testicular cancer.
J Psychosom Res 2008 Apr;64(4):363-71.
PMID: 18374735
Posterior uveal melanoma. Distribution of the sites of origin and patterns of tumour extent in the ocular fundus.
Br J Ophthalmol 2008 Jun;92(6):751-6.
PMID: 18523080
Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma model.
Int J Hyperthermia 2008 Aug;24(5):425-41.
PMID: 18608572
Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy.
Acta Oncol 2008;47(7):1257-64.
PMID: 18618299
2008 ESHO-BSD Award Winner--Gerard C. van Rhoon.
Int J Hyperthermia 2008 Aug;24(5):444-5.
PMID: 18716944
Predicted cardiovascular mortality and reported cardiovascular morbidity in testicular cancer survivors.
J Cancer Surviv 2008 Sep;2(3):128-37. Epub 2008 mai 29
PMID: 18792787
Release of angiopoietin-1 by primary human acute myelogenous leukemia cells is associated with mutations of nucleophosmin, increased by bone marrow stromal cells and possibly antagonized by high systemic angiopoietin-2 levels.
Leukemia 2008 Feb;22(2):287-93. Epub 2007 okt 18
PMID: 17943167
Abolition of stress-induced protein synthesis sensitizes leukemia cells to anthracycline-induced death.
Blood 2008 Mar;111(5):2866-77. Epub 2008 jan 8
PMID: 18182573
Review: genetic models of acute myeloid leukaemia.
Oncogene 2008 Jun;27(27):3765-79. Epub 2008 feb 11
PMID: 18264136
Erythropoietin a safe bet in haemorrhagic shock?
Acta Anaesthesiol Scand 2008 May;52(5):585-6.
PMID: 18419707
In vivo biological effects of ATRA in the treatment of AML.
Expert Opin Investig Drugs 2008 Nov;17(11):1623-33.
PMID: 18922099
Anticancer immunotherapy in combination with proapoptotic therapy.
Curr Cancer Drug Targets 2008 Dec;8(8):666-75.
PMID: 19075589
Platelet functions and clinical effects in acute myelogenous leukemia.
Thromb Haemost 2008 Jan;99(1):27-37.
PMID: 18217131
Platelet-released supernatants enhance hematopoietic stem cell proliferation in vitro.
Platelets 2008 Mar;19(2):155-9.
PMID: 18297552
Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Transfusion 2008 May;48(5):877-83. Epub 2008 feb 21
PMID: 18298599
In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
J Interferon Cytokine Res 2008 May;28(5):297-310.
PMID: 18547160
[Changes in smoking habits among medical students in Bergen 2004-2006]
Tidsskr Nor Laegeforen 2008 Aug;128(16):1812-4.
PMID: 18787589
Aromatase inhibitors: assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression.
J Steroid Biochem Mol Biol 2008 Feb;108(3-5):196-202. Epub 2007 sep 14
PMID: 17996443
An optimised, highly sensitive radioimmunoassay for the simultaneous measurement of estrone, estradiol and estrone sulfate in the ultra-low range in human plasma samples.
J Steroid Biochem Mol Biol 2008 Mar;109(1-2):90-5. Epub 2007 des 15
PMID: 18242079
Indications and limitations of third-generation aromatase inhibitors.
Expert Opin Investig Drugs 2008 May;17(5):723-39.
PMID: 18447598
The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling.
Oncogene 2008 Sep;27(39):5182-94. Epub 2008 mai 12
PMID: 18469852
Pathway based analysis of SNPs with relevance to 5-FU therapy: relation to intratumoral mRNA expression and survival.
Int J Cancer 2008 Aug;123(3):577-85.
PMID: 18498133
Exploring the lack of cross-resistance between aromatase inhibitors: evidence for a difference?
Anticancer Drugs 2008 Mar;19 Suppl 2():S11-3.
PMID: 18337640
Experience with exemestane in the treatment of early and advanced breast cancer.
Expert Opin Drug Metab Toxicol 2008 Jul;4(7):987-97.
PMID: 18624685
GSTP1 promoter haplotypes affect DNA methylation levels and promoter activity in breast carcinomas.
Cancer Res 2008 Jul;68(14):5562-71.
PMID: 18632608
Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?
Oncologist 2008 Aug;13(8):829-37. Epub 2008 aug 11
PMID: 18695261
Endocrine therapy and bone loss in breast cancer: time to close in the RANK(L)?
J Clin Oncol 2008 Oct;26(30):4859-61. Epub 2008 aug 25
PMID: 18725646
Aromatase inhibition versus placebo.
Clin Breast Cancer 2008 Aug;8(4):374.
PMID: 18757268
Letrozole is superior to anastrozole in suppressing breast cancer tissue and plasma estrogen levels.
Clin Cancer Res 2008 Oct;14(19):6330-5.
PMID: 18829517
Early gene expression of acute myeloid leukemia in response to chemotherapy.
Expert Rev Anticancer Ther 2007 May;7(5):741-51.
PMID: 17492937
Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling.
Expert Opin Ther Targets 2007 Aug;11(8):1055-69.
PMID: 17665978
Flt3 Y591 duplication and Bcl-2 overexpression are detected in acute myeloid leukemia cells with high levels of phosphorylated wild-type p53.
Blood 2007 Mar;109(6):2589-96. Epub 2006 nov 14
PMID: 17105820
T cells remaining after intensive chemotherapy for acute myelogenous leukemia show a broad cytokine release profile including high levels of interferon-gamma that can be further increased by a novel protein kinase C agonist PEP005.
Cancer Immunol Immunother 2007 Jun;56(6):913-25. Epub 2006 nov 8
PMID: 17115221
Subclassification of patients with acute myelogenous leukemia based on chemokine responsiveness and constitutive chemokine release by their leukemic cells.
Haematologica 2007 Mar;92(3):332-41.
PMID: 17339182
The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells.
Br J Haematol 2007 Mar;136(6):814-28.
PMID: 17341267
Clonogenic acute myelogenous leukemia cells are heterogeneous with regard to regulation of differentiation and effect of epigenetic pharmacological targeting.
Leuk Res 2007 Sep;31(9):1303-13. Epub 2007 apr 9
PMID: 17416413
In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage.
Transfusion 2007 Apr;47(4):653-65.
PMID: 17381624
Comparison of nucleic acid targets prepared from total RNA or poly(A) RNA for DNA oligonucleotide microarray hybridization.
Anal Biochem 2007 Jul;366(1):46-58. Epub 2007 mar 18
PMID: 17449007
Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex.
Hematology 2007 Jun;12(3):199-207.
PMID: 17558695
Cyclin B1 is commonly expressed in the cytoplasm of primary human acute myelogenous leukemia cells and serves as a leukemia-associated antigen associated with autoantibody response in a subset of patients.
Eur J Haematol 2007 Sep;79(3):210-25. Epub 2007 jul 26
PMID: 17655707
Functional characteristics and gene expression profiles of primary acute myeloid leukaemia cells identify patient subgroups that differ in susceptibility to histone deacetylase inhibitors.
Int J Oncol 2007 Dec;31(6):1529-38.
PMID: 17982680
Components of the metabolic syndrome in long-term survivors of testicular cancer.
Ann Oncol 2007 Feb;18(2):241-8. Epub 2006 okt 23
PMID: 17060482
Transient neurological adverse effects following low dose radiation therapy for early stage testicular seminoma.
Radiother Oncol 2007 Feb;82(2):137-44. Epub 2006 des 26
PMID: 17189656
Clinical characteristics and outcomes in patients with advanced rectal cancer: a national prospective cohort study.
Dis Colon Rectum 2007 Mar;50(3):285-91.
PMID: 17235720
Quantification of S100A12 (EN-RAGE) in blood varies with sampling method, calcium and heparin.
Scand J Immunol 2007 Feb;65(2):192-201.
PMID: 17257225
Is the sexual function compromised in long-term testicular cancer survivors?
Eur Urol 2007 Nov;52(5):1438-47. Epub 2007 mar 1
PMID: 17350159
Gonadal dysfunction and fertility problems in cancer survivors.
Acta Oncol 2007;46(4):480-9.
PMID: 17497315
Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy.
Acta Oncol 2007;46(5):639-50.
PMID: 17562440
Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer.
Acta Oncol 2007;46(7):982-8.
PMID: 17917829
[Radiotherapy of rectal cancer.]
Tidsskr Nor Laegeforen 2007 Nov;127(23):3090-3.
PMID: 18049501
[Adjuvant chemotherapy for colon cancer]
Tidsskr Nor Laegeforen 2007 Nov;127(23):3094-6.
PMID: 18049502
Breast cancer prognostication and prediction: are we making progress?
Ann Oncol 2007 Sep;18 Suppl 8():viii3-7.
PMID: 17890212
Replication protein A prevents accumulation of single-stranded telomeric DNA in cells that use alternative lengthening of telomeres.
Nucleic Acids Res 2007;35(21):7267-78. Epub 2007 okt 24
PMID: 17959650
Aromatase inhibitors--socioeconomical issues.
J Steroid Biochem Mol Biol 2007 Aug-Sep;106(1-5):55-61. Epub 2007 mai 24
PMID: 17604616
Adjuvant endocrine treatment of early breast cancer.
Hematol Oncol Clin North Am 2007 Apr;21(2):223-38.
PMID: 17512446
Amplification of TOP2A and HER-2 genes in breast cancers occurring in patients harbouring BRCA1 germline mutations.
Acta Oncol 2007;46(2):199-203.
PMID: 17453369
Trastuzumab in adjuvant breast cancer therapy. A model based cost-effectiveness analysis.
Acta Oncol 2007;46(2):153-64.
PMID: 17453363
Mutations and polymorphisms of the p21B transcript in breast cancer.
Int J Cancer 2007 Aug;121(4):908-10.
PMID: 17443496
Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.
J Steroid Biochem Mol Biol 2007 Apr;104(1-2):27-34. Epub 2007 mar 9
PMID: 17350249
Breast cancer prognostication and prediction in the postgenomic era.
Ann Oncol 2007 Aug;18(8):1293-306. Epub 2007 feb 21
PMID: 17317675
P21/WAF1 mutation and drug resistance to paclitaxel in locally advanced breast cancer.
Int J Cancer 2007 Jun;120(12):2749.
PMID: 17315192
Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.
Lancet 2007 Feb;369(9561):559-70.
PMID: 17307102
ABCB1 and GST polymorphisms associated with TP53 status in breast cancer.
Pharmacogenet Genomics 2007 Feb;17(2):127-36.
PMID: 17301692
Comparing cost/utility of giving an aromatase inhibitor as monotherapy for 5 years versus sequential administration following 2-3 or 5 years of tamoxifen as adjuvant treatment for postmenopausal breast cancer.
Ann Oncol 2006 Feb;17(2):217-25. Epub 2005 nov 2
PMID: 16267126
T lymphocyte chemotactic chemokines in acute myelogenous leukemia (AML): local release by native human AML blasts and systemic levels of CXCL10 (IP-10), CCL5 (RANTES) and CCL17 (TARC).
Cancer Immunol Immunother 2006 Jul;55(7):830-40. Epub 2005 nov 3
PMID: 16267679
CaM-kinaseII-dependent commitment to microcystin-induced apoptosis is coupled to cell budding, but not to shrinkage or chromatin hypercondensation.
Cell Death Differ 2006 Jul;13(7):1191-202. Epub 2005 nov 25
PMID: 16311514
Aromatase inhibitors as adjuvant treatment of breast cancer.
Crit Rev Oncol Hematol 2006 Jan;57(1):53-61. Epub 2005 des 7
PMID: 16337805
Multilocus analysis of SNP and metabolic data within a given pathway.
BMC Genomics 2006 Jan;7(1):5. Epub 2006 jan 13
PMID: 16412218
Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation technique.
Cancer Immunol Immunother 2006 Oct;55(10):1280-4. Epub 2006 jan 21
PMID: 16429314
Acute myelogenous leukemia in a patient with Li-Fraumeni syndrome treated with valproic acid, theophyllamine and all-trans retinoic acid: a case report.
Leukemia 2006 Apr;20(4):734-6.
PMID: 16437140
Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.
Expert Opin Ther Targets 2006 Feb;10(1):51-68.
PMID: 16441228
Nationwide quality assurance of rectal cancer treatment.
Colorectal Dis 2006 Mar;8(3):224-9.
PMID: 16466564
Antitumor efficacy improved by local delivery of species-specific endostatin.
J Neurosurg 2006 Jan;104(1):118-28.
PMID: 16509155
Evaluation of MetriGenix custom 4D arrays applied for detection of breast cancer subtypes.
BMC Cancer 2006;6():59. Epub 2006 mar 15
PMID: 16536878
Yo antibodies in ovarian and breast cancer patients detected by a sensitive immunoprecipitation technique.
Clin Exp Immunol 2006 Apr;144(1):53-8.
PMID: 16542365
cDNA microarray analysis of non-selected cases of acute myeloid leukemia demonstrates distinct clustering independent of cytogenetic aberrations and consistent with morphological signs of differentiation.
Int J Oncol 2006 May;28(5):1065-80.
PMID: 16596222
Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90.
Leuk Res 2006 Dec;30(12):1531-40. Epub 2006 apr 5
PMID: 16600371
Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variables.
BMC Bioinformatics 2006;7():198. Epub 2006 apr 10
PMID: 16606449
Interaction between p53 staining and high-dose chemotherapy in breast cancer.
Clin Cancer Res 2006 Apr;12(7 Pt 1):2289.
PMID: 16609046
A phase II trial of pegylated interferon alpha-2b therapy for polycythemia vera and essential thrombocythemia: feasibility, clinical and biologic effects, and impact on quality of life.
Cancer 2006 Jun;106(11):2397-405.
PMID: 16639737
Treatment with valproic acid, all-trans retinoic acid (ATRA) and theophyllamine for 9 days caused a persistent increase in peripheral blood platelet counts for a patient with acute myelogenous leukemia.
Acta Oncol 2006;45(3):346-9.
PMID: 16644583
Gene expression in poorly differentiated papillary thyroid carcinomas.
Thyroid 2006 Feb;16(2):161-75.
PMID: 16676402
Genetic variation in putative regulatory loci controlling gene expression in breast cancer.
Proc Natl Acad Sci U S A 2006 May;103(20):7735-40. Epub 2006 mai 9
PMID: 16684880
Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage.
Transfusion 2006 May;46(5):800-10.
PMID: 16686848
Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelines.
J Clin Oncol 2006 Jun;24(16):2444-7.
PMID: 16735701
Radiation dose escalation combined with hormone therapy improves outcome in localised prostate cancer.
Acta Oncol 2006;45(4):454-62.
PMID: 16760182
Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML).
Curr Pharm Biotechnol 2006 Jun;7(3):159-70.
PMID: 16789901
Proteomics approaches to elucidate oncogenic tyrosine kinase signaling in myeloid malignancies.
Curr Pharm Biotechnol 2006 Jun;7(3):185-98.
PMID: 16789903
Proteomics of p53 in diagnostics and therapy of acute myeloid leukemia.
Curr Pharm Biotechnol 2006 Jun;7(3):199-207.
PMID: 16789904
Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
J Gene Med 2006 Sep;8(9):1131-40.
PMID: 16810631
Does adjuvant therapy with letrozole improve survival in postmenopausal women with early-stage breast cancer?
Nat Clin Pract Oncol 2006 Jul;3(7):356-7.
PMID: 16826213
Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.
J Cell Sci 2006 Aug;119(Pt 16):3284-95. Epub 2006 jul 25
PMID: 16868026
A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy.
Radiother Oncol 2006 Jul;80(1):98-105. Epub 2006 jul 28
PMID: 16876274
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer.
Genes Chromosomes Cancer 2006 Nov;45(11):1033-40.
PMID: 16897746
Microvascular endothelial cells increase proliferation and inhibit apoptosis of native human acute myelogenous leukemia blasts.
Int J Cancer 2006 Nov;119(10):2313-21.
PMID: 16921487
Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Platelets 2006 Aug;17(5):296-302.
PMID: 16928601
Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study.
Eur J Cancer 2006 Nov;42(17):2968-75. Epub 2006 sep 11
PMID: 16963261
Adaptive contrast enhancement of two-dimensional electrophoretic protein gel images facilitates visualization, orientation and alignment.
Electrophoresis 2006 Oct;27(20):4086-95.
PMID: 16983632
A novel type of deletion in the CDKN2A gene identified in a melanoma-prone family.
Genes Chromosomes Cancer 2006 Dec;45(12):1155-63.
PMID: 17001621
Bone safety of aromatase inhibitors versus tamoxifen.
Int J Gynecol Cancer 2006;16 Suppl 2():518-20.
PMID: 17010062
Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters.
Mol Cancer 2006;5():47. Epub 2006 okt 20
PMID: 17054774
The novel p21 polymorphism p21G251A is associated with locally advanced breast cancer.
Clin Cancer Res 2006 Oct;12(20 Pt 1):6000-4.
PMID: 17062672
Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer.
Mol Cancer Ther 2006 Nov;5(11):2914-8.
PMID: 17121939
Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts.
Hum Gene Ther 2005 Mar;16(3):381-92.
PMID: 15812233
Aromatase inhibition: translation into a successful therapeutic approach.
Clin Cancer Res 2005 Apr;11(8):2809-21.
PMID: 15837728
Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancer.
J Clin Oncol 2005 Aug;23(22):5126-37. Epub 2005 jun 27
PMID: 15983390
Treatment with high-dose estrogen (diethylstilbestrol) significantly decreases plasma estrogen and androgen levels but does not influence in vivo aromatization in postmenopausal breast cancer patients.
J Steroid Biochem Mol Biol 2005 Sep;96(5):415-22.
PMID: 16168635
Genomics in breast cancer-therapeutic implications.
Nat Clin Pract Oncol 2005 Jan;2(1):26-33.
PMID: 16264853
Adjuvant chemotherapy in colorectal cancer: a joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.
Acta Oncol 2005;44(8):904-12.
PMID: 16332600
Single cell profiling of potentiated phospho-protein networks in cancer cells.
Cell 2004 Jul;118(2):217-28.
PMID: 15260991
Epigenetic targetting in acute myeloid leukemia: use of flow cytometry in monitoring therapeutic effects
Curr Pharmaceutical Biotechnol 2007, 8, 404-11
Global gene expression in classification, pathogenetic understanding and identification of therapeutic targets in acute myeloid
Curr Pharmaceutical Biotechnol 2007, 8, 344-54
Introduction: RNA and the treatment of human cancer
Curr Pharmaceutical Biotechnol 2007, 8, 318-9
Histone deacetylase inhibitors in cancer treatment: a review of the clinical toxicity and the modulation of gene expression in c
Curr Pharmaceutical Biotechnol 2007, 8, 388-400
The immunological dilemma: Cellular innate and adaptive immune response versus human acute myeloid leukemia
Open Hematol Rev 2007,7,1-14
Hormonal therapies of metastatic breast cancer: the past and the present
Cancer metastasis-Biology and Treatment 11: Metastasis of breast cancer. Eds. Mansel RE, Foc Springer Publishers, Dordrecht, Netherlands; 405-423, 2007
Adjuvant treatment: the contribution of expression micro-arrays
Breast Cancer Res 9(S2):s14;1-5, 2007
Legemidler i behandlingen av kreftsykdommer
Legemiddelhåndboken, Ed. A Vilberg. pp.703-740, Oslo 2007
Kreftsykdommer
Legemiddelhåndboken, Ed. A Vilberg. pp.93-112, Oslo 2007
Hypoxic responses in acute myeloid leukaemia (AML)
Cell signalling World 2006, Luxembourg, Januar 2006
Nye strategier for behandling av akutt blodkreft
- Disputert:
- april 2008
- Hovedveileder:
- Øystein Bruserud og Bjørn Tore Gjertsen
Kjemokin-nettverket i akutt myelogen leukemi
- Disputert:
- juni 2008
- Hovedveileder:
- Øystein Bruserud og Anita Ryningen
Chemoresistance in breast cancer: Alterations in the p53 pathway and integrity of the DNA damage.
- Disputert:
- februar 2007
- Hovedveileder:
- Per Eystein Lønning
Germline genetic alterations affecting CDKN2A, MDM2 and CDKN1A in melanoma and breast cancer
- Disputert:
- mars 2007
- Hovedveileder:
- Per Eystein Lønning
Immunological aspects of acute myelogenous leukemia
- Disputert:
- februar 2007
- Hovedveileder:
- Øystein Bruserud
Flt3 receptor tyrosine kinase in AML and its modulation of the p53/Hdm2/Bcl-2 pathway
- Disputert:
- august 2007
- Hovedveileder:
- Bjørn Tore Gjertsen
Inflammatory biomarkers with focus on Calprotectin (S100A8/S100A9) and S100A12 (en rage). Method development and application in
- Disputert:
- februar 2007
- Hovedveileder:
- Olav Dahl
Studies on viral gene transfer and angiogenesis inhibition in experimental glioma models
- Disputert:
- november 2006
- Hovedveileder:
- Rolf Bjerkvig og Per Eystein Lønning
p53 protein biosignatures in acute myeloid leukemia
- Disputert:
- mars 2006
- Hovedveileder:
- Bjørn Tore Gjertsen
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest